STOCK TITAN
  1. Home
  2. Sec-filings
  3. GEVO
  4. [144] Gevo, Inc. SEC Filing

Gevo (NASDAQ: GEVO) insider plans to sell 39,957 shares after prior sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Gevo, Inc. insider Christopher Ryan has filed to sell up to 39,957 shares of common stock through Stifel Nicolaus & Company on the Nasdaq on or after August 6, 2026, with an indicated aggregate market value of $61,765.53 for the planned sale.

The filing references 88,740 shares of common stock acquired as Restricted Stock Awards on August 3, 2023 as equity compensation. It also lists recent sales by Ryan of 87,700 shares for $154,334.00 on May 27, 2026 and 35,196 shares for $50,161.00 on June 12, 2026, and notes 243,411,329 shares of Gevo common stock outstanding.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 39,957 shares Common stock to be sold through Stifel Nicolaus & Company on or after August 6, 2026
Aggregate market value of planned sale $61,765.53 Indicated aggregate market value for 39,957 shares of common stock
Shares acquired as Restricted Stock Awards 88,740 shares Common stock received as Restricted Stock Awards on August 3, 2023 as equity compensation
Recent sale on May 27, 2026 87,700 shares for $154,334.00 Common stock sold during the past 3 months
Recent sale on June 12, 2026 35,196 shares for $50,161.00 Common stock sold during the past 3 months
Shares outstanding 243,411,329 shares Gevo common stock outstanding cited in connection with the planned sale
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Awards financial
"Common Stock | 08/03/2023 | Restricted Stock Awards | Issuer"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Equity Compensation financial
"88740 | 08/06/2026 | Equity Compensation"
Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does the GEVO Form 144 filing by Christopher Ryan disclose?
The filing shows Christopher Ryan plans to sell up to 39,957 GEVO shares through Stifel on Nasdaq, with an indicated market value of $61,765.53. It also details prior sales and equity compensation-related Restricted Stock Awards.

How many GEVO shares is Christopher Ryan planning to sell under this notice?
Christopher Ryan plans to sell up to 39,957 shares of GEVO common stock. The planned transaction has an indicated aggregate market value of $61,765.53 and is expected to be executed through Stifel Nicolaus & Company on Nasdaq.

What recent GEVO share sales by Christopher Ryan are reported in this Form 144?
The notice reports Ryan sold 87,700 GEVO shares for $154,334.00 on May 27, 2026 and 35,196 shares for $50,161.00 on June 12, 2026. These transactions occurred in the three months preceding the new planned sale.

What equity compensation information for GEVO is included in Christopher Ryan’s filing?
The filing notes Ryan received 88,740 GEVO common shares as Restricted Stock Awards on August 3, 2023 as equity compensation. This award is cited as the source of some of the shares referenced in the planned and prior sales.

How many GEVO shares are outstanding according to this Form 144 filing?
The filing cites 243,411,329 GEVO common shares outstanding as a reference figure. This number provides context for the size of Christopher Ryan’s planned and recent sales relative to the company’s total common stock base.

Which broker and market are involved in the planned GEVO stock sale?
The planned sale of 39,957 GEVO shares will be handled by Stifel Nicolaus & Company Inc. with trading on the Nasdaq market. The indicated date for this planned transaction is August 6, 2026.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR